Inflammatory Markers in Coronary Artery Disease

Interrelationship of interleukin 6, C-reactive protein and Chlamydia pneumoniae IgG antibodies in patients with acute coronary syndromes

“…This distinction between lesions versus lumen diameter challenges our traditional reliance upon coronary anatomy. As in the initiation and progression of arteriosclerosis, ample data support the involvement of inflammation in these thrombotic complications of arteriosclerosis [10][11][12][13] . The inflammatory stimuli produced by primary proinflammatory cytokines may undergo amplification through the induction of IL-6 production.…”

Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients

“…Several mediators of this process, with varying biological roles, indicate the intensity of local and systemic inflammatory activity. The importance of these biomarkers is the potential to early identify patients who are vulnerable for developing cardiovascular events [17][18][19][20].…”

Anti-Inflammatory Effects of Pioglitazone and/or Simvastatin in High Cardiovascular Risk Patients With Elevated High Sensitivity C-Reactive Protein

“…Inflammatory activity has been shown to predict myocardial infarction and stroke in patients with pre-existing cardiovascular disease (CVD). Numerous inflammatory parameters, such as cell adhesion molecules, cytokines, chemokines, and acute phase reactants, have been identified as valuable risk markers for the prediction of cardiovascular events (1,2). The inflammatory phase protein, C-reactive protein (CRP), is associated with an increased risk for CVD and stroke.…”